85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details


臨床試験数 : 627 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

  
7 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2004-001261-17-IE
(EUCTR)
28/01/200508/12/2004An Open-Label Study of the Safety of Subcutaneous Recombinant Interferon gamma-1b in Patients with Idiopathic Pulmonary FibrosisAn Open-Label Study of the Safety of Subcutaneous Recombinant Interferon gamma-1b in Patients with Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis (IPF)Trade Name: Immukin
Product Name: Interferon gamma-1b
InterMuneNULLNot RecruitingFemale: yes
Male: yes
Phase 3Ireland
2EUCTR2004-000029-31-IE
(EUCTR)
28/01/200508/12/2004A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Safety and Efficacy of Interferon gamma-Ib in patients with Idiopathic Pulmonary Fibrosis The INSPIRE Trial - International Study of Survival outcomes in IPF with Interferon gamma-1b) - INSPIREA Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Safety and Efficacy of Interferon gamma-Ib in patients with Idiopathic Pulmonary Fibrosis The INSPIRE Trial - International Study of Survival outcomes in IPF with Interferon gamma-1b) - INSPIRE Idiopathic Pulmonary Fibrosis (IPF)Trade Name: Immukin
Product Name: Interferon gamma-1b
InterMuneNULLNot RecruitingFemale: yes
Male: yes
600Phase 3Ireland
3NCT00075998
(ClinicalTrials.gov)
December 200312/1/2004The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Safety and Efficacy of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (The INSPIRE Trial)Idiopathic Pulmonary Fibrosis;Lung Disease;Pulmonary FibrosisDrug: Interferon gamma-1b (Actimmune)InterMuneNULLTerminated40 Years79 YearsBoth826Phase 3United States
4NCT00076635
(ClinicalTrials.gov)
November 200328/1/2004An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPFAn Open-Label Study of the Safety of Subcutaneous Recombinant Interferon Gamma-1b in Patients With Idiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosis;Pulmonary Fibrosis;Lung DiseaseDrug: Interferon gamma-1bInterMuneNULLTerminatedN/AN/ABoth91Phase 3United States
5NCT00052052
(ClinicalTrials.gov)
September 200221/1/2003An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis.Lung Disease;Pulmonary FibrosisDrug: interferon-gamma 1bInterMuneNULLCompleted20 Years79 YearsBoth210Phase 2United States
6NCT00052039
(ClinicalTrials.gov)
April 200221/1/2003A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving PrednisoneA Randomized, Double-Blind, Three-Arm, Phase IIIb Study Comparing the Safety and Efficacy of Interferon Gamma-1b Alone, IFN-Gamma 1b With Azathioprine, and Azathioprine Alone in Patients With Idiopathic Pulmonary Fibrosis Receiving PrednisoneLung Disease;Pulmonary FibrosisDrug: interferon-gamma 1b;Drug: azathioprineInterMuneNULLTerminated20 Years79 YearsBoth0Phase 3Italy
7NCT00047658
(ClinicalTrials.gov)
November 20019/10/2002A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Biology, and Clinical Effects of Interferon Gamma-1b Administered Subcutaneously to Patients With IPF Followed by an Open-Label ExtensionIdiopathic Pulmonary FibrosisDrug: Interferon-gamma 1bInterMuneNULLCompleted20 Years79 YearsBoth32Phase 2United States